Astronics Corp

ATRO remains entrenched in a Stage 4 decline with a confirmed support failure and sequential lower highs and lower lows under declining short‐term EMAs and the 50 DMA. Medium‐term bias is bearish, but price is now extended below the EMA cluster and oversold, making immediate selling unfavorable. Optimal execution is to defer and sell into rallies up to the declining 9/21/50 EMA zone for rejection.

• ↑2026 revenue guided at $970M–$1B, implying 14–16% YoY growth
• ↑Q1 bookings reached $290M, driving $734M backlog for future sales
• ↓Negative earnings yield underscores weak profitability capacity